These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30909062)

  • 1. Glucose to Lymphocyte Ratio as a Prognostic Marker in Patients With Resected pT2 Gallbladder Cancer.
    Navarro J; Kang I; Hwang HK; Yoon DS; Lee WJ; Kang CM
    J Surg Res; 2019 Aug; 240():17-29. PubMed ID: 30909062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Factors for Operated Gallbladder Cancer.
    Oven Ustaalioglu BB; Bilici A; Seker M; Kefeli U; Aydin D; Celik S; Demir T; Erkol B
    J Gastrointest Cancer; 2019 Sep; 50(3):451-457. PubMed ID: 29637517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study.
    Lee W; Jeong CY; Jang JY; Kim YH; Roh YH; Kim KW; Kang SH; Yoon MH; Seo HI; Yun SP; Park JI; Jung BH; Shin DH; Choi YI; Moon HH; Chu CW; Ryu JH; Yang K; Park YM; Hong SC
    Surgery; 2017 Sep; 162(3):515-524. PubMed ID: 28629653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre study.
    Kwon W; Kim H; Han Y; Hwang YJ; Kim SG; Kwon HJ; Vinuela E; Járufe N; Roa JC; Han IW; Heo JS; Choi SH; Choi DW; Ahn KS; Kang KJ; Lee W; Jeong CY; Hong SC; Troncoso AT; Losada HM; Han SS; Park SJ; Kim SW; Yanagimoto H; Endo I; Kubota K; Wakai T; Ajiki T; Adsay NV; Jang JY
    Br J Surg; 2020 Sep; 107(10):1334-1343. PubMed ID: 32452559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C-reactive protein to albumin ratio is an excellent prognostic predictor for gallbladder cancer.
    Bao Y; Yang J; Duan Y; Chen Y; Chen W; Sun D
    Biosci Trends; 2021 Jan; 14(6):428-435. PubMed ID: 33239498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Surgical Methods and Tumor Location on Survival and Recurrence Patterns after Curative Resection in Patients with T2 Gallbladder Cancer.
    Jung W; Jang JY; Kang MJ; Chang YR; Shin YC; Chang J; Kim SW
    Gut Liver; 2016 Jan; 10(1):140-6. PubMed ID: 26347513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma.
    Wu XS; Shi LB; Li ML; Ding Q; Weng H; Wu WG; Cao Y; Bao RF; Shu YJ; Ding QC; Mu JS; Gu J; Dong P; Liu YB
    Ann Surg Oncol; 2014 Feb; 21(2):449-57. PubMed ID: 24081806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Surgical Procedures for T2 Gallbladder Cancer in Terms of Recurrence and Prognosis.
    Kawahara R; Shirahama T; Arai S; Muroya D; Nomura Y; Fukutomi S; Shirahama N; Takagi K; Goto Y; Akashi M; Maruyama Y; Sakai H; Ishikawa H; Hisaka T; Yasunaga M; Horiuchi H; Okuda K; Akagi Y; Tanaka H
    Kurume Med J; 2017 Apr; 63(1.2):15-22. PubMed ID: 28331137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium.
    Margonis GA; Gani F; Buettner S; Amini N; Sasaki K; Andreatos N; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Pawlik TM
    HPB (Oxford); 2016 Nov; 18(11):872-878. PubMed ID: 27527802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
    BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study.
    Shindoh J; de Aretxabala X; Aloia TA; Roa JC; Roa I; Zimmitti G; Javle M; Conrad C; Maru DM; Aoki T; Vigano L; Ribero D; Kokudo N; Capussotti L; Vauthey JN
    Ann Surg; 2015 Apr; 261(4):733-9. PubMed ID: 24854451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer.
    Jensen EH; Abraham A; Jarosek S; Habermann EB; Al-Refaie WB; Vickers SA; Virnig BA; Tuttle TM
    Surgery; 2009 Oct; 146(4):706-11; discussion 711-3. PubMed ID: 19789030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer.
    Chijiiwa K; Nakano K; Ueda J; Noshiro H; Nagai E; Yamaguchi K; Tanaka M
    J Am Coll Surg; 2001 May; 192(5):600-7. PubMed ID: 11333097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma.
    Aramaki M; Matsumoto T; Shibata K; Himeno Y; Yada K; Hirano S; Sasaki A; Kawano K; Kitano S
    Hepatogastroenterology; 2004; 51(60):1609-11. PubMed ID: 15532788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer.
    Hannarici Z; Yılmaz A; Buyukbayram ME; Turhan A; Çağlar AA; Bilici M; Tekin SB
    Future Oncol; 2023 Feb; 19(4):315-325. PubMed ID: 37125596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing survival rate and appropriate surgery methods according to tumor location in T2 gallbladder cancer.
    Sung MK; Lee W; Lee JH; Song KB; Kim SC; Kwak BJ; Hwang DW
    Surg Oncol; 2022 Mar; 40():101693. PubMed ID: 34923377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the fibrinogen-to-albumin ratio in gallbladder cancer patients.
    Xu WY; Zhang HH; Xiong JP; Yang XB; Bai Y; Lin JZ; Long JY; Zheng YC; Zhao HT; Sang XT
    World J Gastroenterol; 2018 Aug; 24(29):3281-3292. PubMed ID: 30090008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery in node-positive gallbladder cancer: The implication of an involved superior retro-pancreatic lymph node.
    Chaudhary RK; Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Kiyohara K; Yamamoto M
    Surgery; 2019 Mar; 165(3):541-547. PubMed ID: 30348459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Oncologic Outcomes for T2 Gallbladder Cancer According to the Type of Surgery Performed and the Optimal Timing for Sequential Extended Cholecystectomy.
    Oh MY; Kim H; Sohn HJ; Lee S; Lee M; Kim HS; Han Y; Kwon W; Jang JY
    J Gastrointest Surg; 2022 Aug; 26(8):1705-1712. PubMed ID: 35641810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].
    Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.